Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
  • C12P5/007—Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
  • C12N15/52—Genes encoding for enzymes or proenzymes
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
  • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
  • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
  • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
  • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P7/00—Preparation of oxygen-containing organic compounds
  • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
  • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Definitions

• the present invention relates to two genes responsible for the synthesis of a mixture of sesquiterpenes and their use for the preparation of these compounds in living organisms such as bacteria, yeasts, animal cells and plants.
• Terpenes are molecules found in all living organisms such as bacteria, fungi, animals, and plants. They form the largest class of natural molecules in the living world. In plants, these molecules are present in the primary metabolism as hormones (gibberellins, cytokinins, brassinosteroids and abscisic acid) or as compounds involved in photosynthesis (carotenoids, chlorophylls, plastoquinones and phytol) as well as in the processes of prenylation of proteins, and in the structure of membranes (sterols). However, terpenoids from secondary metabolism account for most of the structural diversity of this class of molecules.
• secondary terpenes are essentially in the field of interactions with the environment, such as the attraction of beneficial insects for the plant (pollination and predators of phytophagous insects), the defense against pathogens and insects, and protection against photo-oxidative stress (Tholl, 2006).
• Terpenes consist of multiple isoprenyl units with 5 carbons.
• the number of isoprenyl units makes it possible to classify them as monoterpenes (compounds containing ten carbon atoms or ClO), sesquiterpenes (C 15), diterpenes (C20), sesterterpenes (C25), triterpenes (C30), tetraterpenes (C40), and and so on.
• the universal precursors of all terpenes are isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Two distinct pathways lead to the formation of IPP and DMAPP.
• mevalonate pathway is localized in the cytoplasm of eukaryotic cells while the other, the methyl-erythritol (MEP) pathway exists only in certain bacteria and plants where it is localized in the chloroplast (Rodriguez-Concepcion and Boronat, 2002). All the steps and all the genes encoding the enzymes of the steps of these two pathways are known in a number of organisms.
• the first step of the terpene biosynthesis from the common precursors IPP and DMAPP is carried out by prenyl diphosphate synthases (or prenyltransferases) which go through the condensation of a homoallyl precursor, IPP, and an allylic precursor (DMAPP). , geranyl diphosphate, farnesyldiphosphate or geranylgeranyldiphosphate), generate prenyldiphosphate chains of variable length.
• prenyldiphosphate synthases There are two major major classes of prenyldiphosphate synthases: czs-prenyltransferases or Z-prenyltransferases and tr ⁇ ns-prenyltransferases or E-prenyltransferases.
• the addition of an IPP occurs with stereospecific removal of a proton at the 2-position to form a new C-C bond and a new double bond in the product.
• the repetition of this stereospecific condensation of IPP with an allylic prenyl diphosphate leads to the synthesis of a specific chain length prenyl diphosphate and stereochemistry data specific to each enzyme.
• the chain length of the final product can vary considerably from a ClO (geranyl diphosphate) to polyprenyldiphosphate precursors of natural latex compounds of several thousand carbon atoms.
• prenyltransferases can be divided into two different genetic families according to the stereochemistry (E or Z) of the double bond formed after each elongation cycle (Poulter, 2006, Liang et al, 2002).
• E-prenyltransferases characterized to date are responsible for the synthesis of short-chain prenyl phosphates (ClO to C50) in configuration E.
• Examples that may be mentioned include geranyl diphosphate synthase (GPS), farnesyl diphosphate synthase (FPS), geranyl geranyl diphosphate synthase (GGPS), octaprenyl diphosphate synthase (OPS), solanesyl diphosphate synthase (SPS) and decaprenyl diphosphate synthase (DPS) which are respectively responsible for the synthesis of (Ej-GPP (ClO), (EEJ -FPP (C 15), (EEEJ-GGPP (C20), (E, E, E, E, E, E, E) -OVV (C40), (E, E, E, E, E, E, E, E) -SVV (C45 ), and (E,
• EJ-FPP is generally the substrate for prenyltransferases responsible for the synthesis of chains greater than 20 carbons.
• the first gene encoding a (Ej-prenyl transferase characterized is that of rat SPF (Clarke et al.
• the first gene encoding a Z-prenyltransferase has been cloned in Micrococus luteus (Shimizu et al, 1998). It encodes a undecaprenyltransferase (UPS) that uses E-FPP as a substrate to form a 55-carbon prenyl diphosphate that has a Z, E-type stereochemistry. This molecule is involved in the biosynthesis of peptidoglycans in the wall of certain bacteria. A homologous sequence has been characterized in Arabidopsis as being responsible for the synthesis of isoprenyl diphosphate in Z, E conformation of 100 to 130 carbons (Oh et al, 2000).
• Isoprenyl diphosphates are the substrates of an enzyme class, terpenes synthases, which allow the formation of the basic skeleton of cyclic terpenes or Acyclic ClO (monoterpene), C15 (sesquiterpene), C20 (diterpene), and C30
• Triterpene (Cane 1999, McMillan and Beale 1999, Wise and Croteau 1999).
• the reaction diversity of these enzymes is responsible for the diversity of cyclic terpene skeletons found in nature.
• Four stereoisomers of farnesyl diphosphate are theoretically possible depending on the stereochemical configuration of the double bonds in position 2 or 6 of the molecule (E, E, Z, E, E, Z or Z, Z).
• E, E-FPP as the substrate.
• sesquiterpene corn synthase (tps4) responsible for the synthesis of a mixture of 14 sesquiterpenes accepted E, E-FPP and ZE-FPP (Kollner et al., 2006), thus showing that sesquiterpene synthases could use other isomers than EE-FPP as a substrate.
• sesquiterpene synthase cloned to date uses ZZ-FPP.
• Glandular trichomes type VI of Solanum habrochaites excrete large quantities of olefin sesquiterpenes belonging to two distinct classes.
• Class I contains, in particular, germacrene B and class II contains inter alia alpha-santalene and alpha-bergamotene.
• the SstlA locus is located on chromosome 6, and the genes of this locus are responsible for the accumulation of class I sesquiterpenes.
• habrochaites located on chromosome 8 controls the accumulation of class II sesquiterpenes such as alpha-santalene but also cis-alpha-bergamotene, trans-alpha-bergamotene, epi-beta-santalene and beta-bergamotene and other unidentified minor compounds. While the coding sequences corresponding to the genes located on the Sstl -A locus have been identified (van der Hoeven et al., 2000), those located on the Sst2 locus were not.
• the present invention relates to two genes responsible for the synthesis of a sesquiterpene mixture composed mainly of alpha-santalene, epi-beta-santalene, cis-alpha-bergamotene, trans-alpha beta-farnesyl diphosphate (ZZ-FPP) and their use for the preparation of these compounds in living organisms such as bacteria, plants.
• this paper describes the identification and characterization of two S. habrochaite genes responsible for the synthesis of class II sesquiterpenes (alpha-santalene, epi-beta-santalene, cis-alpha-bergamotene, trans-alpha -bergamotene and endo-beta-bergamotene among others) of S. habrochaites that we have renamed sesquiterpenes of type SB (for Santalene and Bergamotene) in the rest of the text.
• the first gene codes for ZZ-farnesyl diphosphate synthase and the second gene for a multiple-product sesquiterpene synthase that uses ZZ-farnesyl diphosphate as the substrate.
• the production of the corresponding recombinant proteins allowed us to demonstrate that the sesquiterpene profile obtained in vitro is identical to that of the tomato Sst2 locus.
• the invention relates to the enzymatic activities of ZZ-FPP bio-synthesis from IPP and DMAP on the one hand, and a sesquiterpene mixture composed mainly of alpha-santalene, epi-beta-santalene , cis-alpha-bergamotene, trans-alpha-bergamotene and endo-beta-bergamotene from ZZ-FPP, the peptide sequences responsible for these activities and the nucleic acid sequences encoding these peptide sequences.
• the invention also relates to methods using these enzymatic activities for the production of these compounds or derivatives thereof.
• the present invention therefore relates to a method for producing a mixture of sesquiterpenes, mainly composed of alpha-santalene, epi-beta-santalene, cis-alpha-bergamotene, trans-alpha-bergamotene and endo-beta.
• -bergamotene from ZZ-FPP in a cell having a source of IPP and DMAP, comprising: a) introducing into said cell a construct carrying an expression cassette comprising a first gene coding for a ZZ-FPS according to the present invention and a construct carrying an expression cassette comprising a second gene coding for a sesquiterpene synthase called SBS according to the present invention; b) culturing the transformed cell under conditions suitable for the expression of said first and second genes; and, c) optionally, harvesting Z Z-FPP or sesquiterpene products of the SBS enzyme or derivatives thereof contained in said cell and / or in the culture medium.
• the present invention relates to an isolated or recombinant protein having Z, Z-FPS activity.
• This protein preferably has a sequence having at least 80% identity with SEQ ID No. 2. It also relates to a nucleic acid comprising a nucleotide sequence coding for such a protein, or a sequence capable of hybridizing thereto. under stringent conditions.
• the present invention also relates to an isolated or recombinant protein having an activity of SB synthase type and having a sequence having at least 80% identity with SEQ ID No. 4. It also relates to a nucleic acid comprising a nucleotide sequence coding for such protein, or a sequence capable of hybridizing to it under stringent conditions.
• the present invention relates to an expression cassette comprising a nucleic acid according to the present invention, a vector comprising an expression cassette or a nucleic acid according to the present invention, a host cell comprising a vector, an expression cassette or an acid nucleic acid according to the present invention, and a non-human transgenic organism comprising a cell, a vector, an expression cassette or a nucleic acid according to the present invention.
• the present invention further relates to a method for producing ZZ-farnesyl diphosphate (ZZ-FPP), or derivatives thereof from IPP and DMAP in a cell having a source of IPP and DMAP, comprising : a) introducing into said cell a construct carrying an expression cassette with a nucleic acid sequence encoding a ZZ-FPS according to the present invention; b) culturing the transformed cell under conditions appropriate for the expression of the gene; and c) optionally, harvesting the one or more derivatives thereof contained in said cell and / or in the culture medium.
• ZZ-FPP ZZ-farnesyl diphosphate
• the present invention relates to the use of a transgenic protein, nucleic acid, host cell or organism according to the present invention for the preparation of ZZ-FPP or SB-type sesquiterpenes, such as alpha-santalene, Pepi-beta-santalene, cis-alpha-bergamotene, trans-alpha-bergamotene and endo-beta-bergamotene, or derivatives thereof such as alpha-santalol, cob beta-santalol, cis-alpha-bergamotol, trans-alpha-bergamotol and beta-bergamotol.
• ZZ-FPP or SB-type sesquiterpenes such as alpha-santalene, Pepi-beta-santalene, cis-alpha-bergamotene, trans-alpha-bergamotene and endo-beta-bergamotene, or derivatives thereof such as alpha-santalol
• the present invention relates to a non-human transgenic cell or organism, characterized in that the class II sesquiterpenes synthesis pathway is blocked by inactivation of either the gene coding for a ZZ-FPS according to the present invention, or the gene coding for an SB synthase according to the present invention, that is to say both genes.
• the present invention further relates to the use of a nucleic acid to identify molecular markers for introducing the corresponding genomic sequences into other cultivated tomato species or varieties (Solarium lycopersicum).
• the nucleotide sequences SEQ ID No. 1 and No. 2 or variants thereof can also be used as molecular markers for the introgression of these sequences into other species or varieties of cultivated tomatoes. .
• the present invention relates to molecular markers comprising all or part of a nucleic acid having at least 80% identity with SEQ ID No. 1 or SEQ ID No. 3 for identifying a genomic polymorphism between S. habrochaites and Solarium type sexually compatible with S. habrochaites in order to introduce the corresponding genes into these species. It also concerns a method consisting of to introduce the zFPS and SBS genes into a non-sexually compatible species with
• the present invention also relates to a method for producing the ZZ-farnesol by dephosphorylation of Z 5 Z-FPP by a phosphatase.
• Figure 1 The possible stereomers of the FPP. All stereoisomers of FPP are biosynthesized from IPP and DMAPP. To date only E, E-farnesyl diphosphate synthase (1) characterized in many organisms, and Z, E-farnesyl diphosphate synthase (2) of Mycobacterium tuberculosis (Schulbach et al, 2000) have been known. (3): ZZ-farnesyl diphosphate synthase tomato according to the present invention; (4): E, Z-farnesyl diphosphate synthase: no enzyme having this activity has been described to date.
• FIG. 2 Schematic representation of T-DNAs carrying Sh-zFPS and Sh-SBS transgenes.
• Km resistance gene to kanamycin
• 35S promoter of the 35S gene of CaMV.
• CBTS-ter terminator of the CBTS gene;
• eCBTSl.O lkb promoter of the CBTS gene fused with CaMV 35S promoter enhancer.
• Sh-zFPS coding phase of the gene coding for tomato zFPS (S. haplochaites LA177);
• Sh-SBS coding phase of the gene coding for the SB synthase of tomato (S.
• Figure 2 T-DNA fragment of the binary vector pLIBRO64;
• Figure 2B T-DNA fragment of the binary vector pLIBRO65.
• FIG. 3 Analysis of Sh-SBS transgene expression in transgenic tobacco leaves. Expression was measured by real-time quantitative PCR using fluorescent probes (®TAQ-MAN, ABI). One of the probes is specific for the Sh-SBS transgene while the other is specific for a tobacco actin gene (control gene).
• the values of the ordinate axis represent the ratio of the powers 2 of the values obtained with the Sh-SBS probe to those obtained with the actin probe (2 SBS / 2 actme ). This ratio expresses the expression ratio of the Sh-SBS transgene to that of actin.
• the values of the x-axis indicate the number of the transgenic lines.
• figure 3A Transgenic Tobacco Lines Incorporating Sh-zFPS and Sh-SBS Transgenes
• Figure 4 GC / MS profile of (ZZ) -carnesol superimposed on farnesols standards (mixture of isomers).
• Figure 4A The gray chromatogram (m / z: 69) corresponds to the product obtained in vitro with the recombinant protein Sh-zFPS-6His. 57z-FPS-6His was incubated with DMAPP and IPP. The isoprenyl diphosphate product was dephosphorylated to an alcohol and purified by liquid chromatography. Peak No. 1 corresponds to ZZ-farnesol. 1.
• the black chromatogram (m / z: 69) corresponds to the farnesol standard consisting of a mixture of isomers (Z, E) -, (E, Z) -, and (E, E) -famosso ⁇ (Fluka) .
• Peak No. 2 corresponds to a mixture of (Z 5 E) - and (E 5 Z) - farnesol and peak No. 3 to (E, E) -farnesol.
• Figure 4B mass spectrum of (ZZ) -farnesol corresponding to peak No. 1.
• Figure 4C Mass spectrum of (Z, E) - and (is, Z) -farnesol (mixture) corresponding to peak No. 2.
• Figure 4D Mass spectrum of (E, E) -farnesol. corresponding to peak # 3.
• Figure 5 GC / MS profile of in vitro activity assays performed with recombinant Sh-zFPS-6His and Sh-SBS-6His proteins: The two recombinant enzymes Sh-zFPS-6His and Sh-SBS-6His were incubated together. with IPP and DMAPP. The reaction mixture was extracted with pentane and analyzed by GC-MS.
• Figure 5A Chromatogram of the product obtained in vitro and 57Z-zFPS 5Tz-SBS Peak 2 is the major product and corresponds to alpha-santalene ..
• Figure 6 Superposition of the GC profiles between the products obtained in vitro with the recombinant enzymes Sh-zFPS- ⁇ is and Sh-SB S-6III, and the exudate of the isogenic recombinant tomato line TA517.
• the plots correspond to the extracted ion m / z 94.
• gray olefins produced in vitro by Sh-zFPS and Sh-KS.
• black exudate from the isogenic line TA517.
• I 5 cz 's-alpha-bergamotene 2 alpha-santalene; 3, trans-alpha-bergamotene; 4, epi-beta-santalene; 5, endo-beta-bergamotene.
• FIG. 7 GC / MS profile of the volatile molecules emitted by a transgenic plant (# 3877) bearing Sh-zFPS and Sh-SBS transgenes.
• the transgenic plant # 3877 has been grown for 24 hours in a controlled atmosphere in a culture chamber.
• the volatile molecules emitted by the plants were trapped on a Super® Q matrix (Alltech) and analyzed by GC / MS.
• the chromatogram (7A) shows several peaks having m / z signatures characteristic of the SB type sesquiterpenes. The peaks were identified by comparison of their retention time and their mass spectrum with those of the TA517 (7B) line. 1, cis-alpha-bergamotene 2, alpha-santalene; 3, trans-alpha-bergamotene; 4, epi-beta-santalene; 5, endo-beta-bergamotene.
• Figure 8 Polymorphism of zFPS gene between S. lycopersicum (Sl) and S. habrochaites (Sh): The complete zFPS gene was amplified by PCR from genomic DNA of S. lycopersicum, S. habrochaites and TA517. The separation of PCR products on 0.8% agarose gel makes it possible to identify 3 bands A, B, C with a size of about 3000, 2500 and 2000 nucleotides respectively. The PCR product corresponding to the band B is specific for the S. h genome and corresponds to the zFPS gene presented in this document, kb: kilobases
• MRNA messenger ribonucleic acid
• DNA deoxyribonucleic acid
• cDNA complementary DNA produced by reverse transcription from mRNA.
• CaMV cauliflower mosaic virus
• GGPP geranyl geranyl diphosphate
• ihpRNAi intron hairpin interfering RNA
• IPP isopentenyl diphosphate
• RACE "rapid amplification of cDNA ends"
• ZZ-farnesyl diphosphate synthase or zFPS is meant an enzyme capable of producing Z, Z-farnesyl diphosphate ((2Z6Z) -farnesyldiphosphate or cis, cis-FPP), from isopentenyl diphosphate (IPP) and dimethyl allyl diphosphate (DMAP).
• ZZ-FPS activity is meant the production of Z, Z-Farnesyl diphosphate from IPP and DMAPP. The ZZ-FPS activity can be measured by measuring the appearance of Z, Z-farnesyl diphosphate.
• SB synthase or SBS is meant an enzyme capable of producing a mixture of sesquiterpenes consisting mainly of alpha-santalene, epi-beta-santalene, cis-alpha-bergamotene, trans-alpha-bergamotene and endo -beta-bergamotene from ZZ-FPP.
• SB-type activity is meant the production of SB-type sesquiterpenes from Z, Z-Farnesyl diphosphate. SB-type activity can be measured by measuring the occurrence of one or more SB type sesquiterpenes. An exemplary activity measurement of type SB is described in the examples.
• SB-type sesquiterpene is meant a mixture of sesquiterpenes mainly composed of alpha-santalene, epi-beta-santalene, cis-alpha-bergamotene, trans-alpha-bergamotene and endo-beta-bergamotene.
• Stringent Hybridization Conditions Generally, stringent conditions for a polynucleotide of given size and sequence are obtained by operating at a temperature of about 5 ° C. to 10 ° C. at a melting temperature (Tm) of the hybrid formed in the same reaction mixture by this polynucleotide and its complement. Stringent hybridization conditions for a given polynucleotide can be identified by those skilled in the art depending on the size and base composition of the polynucleotide of interest, as well as the composition of the hybridization mixture. (in particular pH and ionic strength). High stringency conditions include a wash step with 0.2 x SSC buffer at 65 ° C.
• heterologous is meant that the gene has been introduced by genetic engineering into the cell. It can be present in episomal or chromosomal form. The origin of the gene may be different from the cell into which it is introduced. However, the gene may also come from the same species as the cell into which it is introduced but is considered heterologous because of its unnatural environment. For example, the gene is said to be heterologous because it is under the control of a promoter other than its natural promoter, it is introduced in a different place from where it is located naturally. The host cell may contain a copy of the endogenous gene prior to the introduction of the heterologous gene or it may not contain an endogenous copy.
• percent identity between two nucleic acid or amino acid sequences within the meaning of the present invention, it is meant to designate a percentage of nucleotides or identical amino acid residues between the two sequences to be compared, obtained after the best alignment, this percentage being purely statistical and the differences between the two sequences being randomly distributed over their entire length.
• the best alignment or alignment is the alignment for which the percentage identity between the two sequences to be compared, as calculated below, is the highest.
• sequence comparisons between two nucleic acid or amino acid sequences are traditionally performed by comparing these sequences after optimally aligning them, said comparison being made by segment or comparison window to identify and compare the local regions of the sequence. sequence similarity.
• the optimal alignment of the sequences for comparison can be realized, besides manually, by means of the local homology algorithm of Smith and Waterman (1981) (Math Ad App 2: 482), using the Neddleman Local Homology Algorithm and
• the percentage identity between two nucleic acid or amino acid sequences is determined by comparing these two optimally aligned sequences by comparison window in which the region of the nucleic acid or amino acid sequence to be compared. may include additions or deletions relative to the reference sequence for optimal alignment between these two sequences.
• the percentage of identity is calculated by determining the number of identical positions for which the nucleotide or amino acid residue is identical between the two sequences, by dividing this number of identical positions by the total number of positions in the comparison window. and multiplying the result obtained by 100 to obtain the percentage identity between these two sequences.
• the present invention thus describes for the first time the genes encoding the enzymes involved in the synthetic route of several sesquiterpenes.
• the present invention relates to the characterization of a multiple product tomato sesquiterpene synthase (SB synthase) which allows the production of a mixture of sesquiterpenes referred to as SB compounds and mainly composed of alpha-santalene, cobalt -beta-tantalene, cis-alpha-bergamotene, trans-alpha-bergamotene and endo-beta-bergamotene from ZZ-FPP.
• SB synthase tomato sesquiterpene synthase synthase
• ZFPS tomato ZZ-farnesyl diphosphate synthase
• zFPS tomato ZZ-farnesyl diphosphate synthase
• These enzymes can be used for the production of SB or ZZ-FPP sesquiterpenes, in vitro or in vivo in transgenic organisms or recombinant cells or microorganisms.
• Transgenic organisms, cells or microorganisms such as bacteria, yeasts, fungi, animal, insect or plant cells and transgenic plants or animals are considered. They also allow the production of compounds derived from ZZ-FPP such as ZZ-farnesol.
• the methods of the present invention are more particularly applicable to the production of ZZ-FPP in microorganisms (bacteria, yeast) and SB-like compounds in plants with trichomes. glandular secretory type.
• the production of the SB-type sesquiterpenes mixture or derivatives thereof can also be decreased or suppressed in plants, for example tomato, by gene extinguishing techniques or by mutagenesis.
• the sequences identified in the present invention are useful for the identification and / or cloning of genes encoding enzymes having the same activities in other species of organisms, particularly plants.
• polymorphic molecular markers can be identified from the nucleic acids encoding zFPS and SB synthase and will track the introduction of the corresponding functional genomic sequences into other cultivated tomato species or varieties (Solarium lycopersicum).
• ZZ-FPP is a potential substrate for sesquiterpene synthases that is not currently commercially available. Although the majority of sesquiterpene synthases characterized to date use E, E-VW, it is also clear that the absence of commercially available Z, Z-FPP has largely limited its use for experimental purposes. Cadinene synthase of cotton is the only example which describes the preferential use of Z, Z-FPP by a sesquiterpene synthase (Heinstein et al, 1970). In this case ZZ-FPP was produced by chemical synthesis, and the ZZ-FPP synthase described in this patent provides a means of producing this molecule in an easy and inexpensive manner.
• SB-type sesquiterpenes contain alpha-santalene, itself a direct precursor of alpha-santalol.
• Alpha-santalol is one of the characteristic components of sandalwood essential oil. Sandalwood oil is extremely popular in perfumery and its cost has increased dramatically over the last 10 years due to overexploitation of sandalwood, mainly in India. This overexploitation poses a threat to the viability of the natural resource of sandalwood.
• Alpha-santalol can be obtained from alpha santalene by simple hydroxylation.
• the present invention therefore relates to a method for producing SB-type sesquiterpenes or derivatives thereof from ZZ-FPP in a cell having a source of DMAP and IPPP, comprising: a) introducing into said cell a a construct carrying an expression cassette comprising a first gene encoding a zFPS according to the present invention and a construct carrying an expression cassette comprising a second gene encoding an SB synthase according to the present invention; b) culturing the transformed cell under conditions suitable for the expression of said first and second genes; and, c) optionally, harvesting SB-type sesquiterpenes or derivatives thereof contained in said cell and / or in the culture medium.
• the SB type sesquiterpenes produced are harvested in step c).
• the SB-type sesquiterpenes produced are selected from alpha-santalene, epi-beta-santalene, alpha-bergamotene, beta-bergamotene, and endo-beta-bergamotene.
• the SB-type sesquiterpenes produced are the starting materials to obtain other compounds of interest such as alpha-santalol.
• SB-type sesquiterpenes derivatives are selected from alpha-santalol, epi-beta-santalol, cis-alpha-bergamotol, trans-alpha-bergamotol and endo-beta. -bergamotol.
• the present invention relates to a method for producing SB-type sesquiterpenes or derivatives thereof from Z Z-FPP in a cell having a source of DMAP and IPPP, comprising: a) the providing a recombinant cell comprising a first heterologous gene encoding a zFPS according to the present invention and a second heterologous gene encoding an SB synthase according to the present invention; b) culturing the cell under conditions suitable for the expression of said first and second genes; and, c) optionally, harvesting SB-type sesquiterpenes or derivatives thereof contained in said cell and / or in the culture medium.
• said cell produces ZZ-FPP.
• ZZ-FPP is provided to the cell.
• the two expression cassettes are carried by the same construction. In another embodiment, the two expression cassettes are carried by two distinct constructions.
• the present invention relates to an isolated or recombinant protein having Z, Z-FPP synthase activity.
• it relates to an isolated or recombinant polypeptide having a activity of ZZ-FPP synthase and whose sequence has at least 80%, 85%, 90%, 95%,
• polypeptide has at least 95% identity with SEQ ID No. 2.
• polypeptide comprises or consists of in the sequence SEQ ID No. 2.
• This polypeptide may also comprise an additional sequence making it possible to facilitate the purification of the enzyme, for example a tag sequence comprising several consecutive histidine amino acids.
• the present invention also relates to an isolated nucleic acid comprising a nucleotide sequence encoding a polypeptide having Z Z-FPP synthase activity and having a sequence of at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 2 or a sequence capable of hybridizing to it under stringent conditions.
• An exemplary nucleic acid is the nucleic acid comprising or consisting of a sequence having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 1 or a sequence complementary to it.
• the present invention provides an isolated nucleic acid capable of hybridizing under high stringency conditions to a nucleic acid that encodes a polypeptide having ZZ-FPP synthase activity and the sequence of said polypeptide having at least 95% or 98% of identity with SEQ ID No. 2.
• the nucleic acid comprises or consists of the sequence SEQ ID No. 1.
• the present invention also relates to an expression cassette, a vector, a host cell or an organism transgenic composition comprising a nucleic acid according to the present invention.
• the nucleic acids can be genomic DNAs, complementary DNAs (cDNAs) or synthetic DNAs. They can be in simple chain or duplex form or a mixture of both.
• the transcribed nucleic acids are preferably cDNAs devoid of introns.
• the transcribed nucleic acids may be synthetic or semi-synthetic, recombinant, optionally amplified or cloned in vectors, chemically modified or comprising non-natural bases. These are typically isolated DNA molecules, synthesized by recombinant techniques well known to those skilled in the art.
• the present invention also relates to an isolated or recombinant polypeptide having SB synthase activity and having a sequence of at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 4.
• the polypeptide comprises or consists of the sequence SEQ ID No. 4.
• the present invention relates to an isolated or recombinant polypeptide having SB synthase activity and whose sequence has at least 95% of identity with SEQ ID No. 4.
• This polypeptide may also comprise an additional sequence to facilitate the purification of the enzyme, for example a tag sequence comprising several consecutive histidine amino acids.
• the present invention also relates to an isolated nucleic acid comprising a nucleotide sequence encoding a polypeptide having SB synthase activity and having a sequence of at least 80%, 85%, 90%, 95%, 97%, 98% or 99% d identity with the
• SEQ ID No. 4 or a sequence capable of hybridizing thereto under stringent conditions.
• An exemplary nucleic acid is the nucleic acid comprising or consisting of a sequence having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 3 or a sequence complementary to it.
• the present invention relates to an isolated nucleic acid capable of hybridizing under high stringency conditions to a nucleic acid that encodes a polypeptide having SB synthase activity and the sequence of said polypeptide having at least 95% or 98% identity with SEQ ID No. 4.
• the nucleic acid comprises or consists of the sequence SEQ ID No. 3.
• the present invention also relates to an expression cassette, a vector, a host cell or a transgenic organism comprising a nucleic acid according to the present invention.
• the present invention particularly relates to a vector, a host cell or a transgenic organism comprising a nucleic acid comprising a heterologous sequence encoding a polypeptide having SB synthase activity and having a sequence of at least 80%, 85%, 90%, 95%. %, 97%, 98% or 99% identity with SEQ ID No
• the transgenic organism is a plant, and in particular a trichomeous plant.
• the present invention also relates to a vector, a host cell or a transgenic organism comprising a nucleic acid comprising a heterologous sequence encoding a polypeptide having SB synthase activity and whose sequence has at least 80%, 85%, 90%, 95% , 97%, 98% or 99% identity with SEQ ID No. 4.
• the present invention further relates to a vector, a host cell or a transgenic organism comprising a nucleic acid comprising a heterologous sequence encoding a polypeptide having Z Z-FPP synthase activity, preferably having a sequence of at least 80%, 85% , 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 2.
• the present invention relates to a method for producing a mixture of SB-type sesquiterpenes or derivatives thereof from IPP and DMAP comprising contacting IPP and DMAP with a recombinant ZZ-FPP synthase. or purified having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 3 and a recombinant or purified SB synthase having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% of identity with SEQ ID No. 4 under appropriate conditions and the collection of a SB-type sesquiterpene mixture or derivatives thereof.
• the present invention relates to a method for producing ZZ-FPP or derivatives thereof from IPP and DMAP comprising contacting IPP and DMAP with a recombinant or purified ZZ-FPP synthase having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 2 under appropriate conditions and the harvest of ZZ-FPP or derivatives thereof.
• the method further comprises incubating the resulting ZZ-FPP with alkaline calf intestinal phosphatase and harvesting ZZ-farnesol.
• the present invention relates to the use of a recombinant or purified ZZ-FPP synthase having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 2 for the preparation of ZZ-FPP or derivatives thereof from IPP and DMAP.
• the present invention relates to a method for producing a mixture of class II sesquiterpenes or derivatives thereof from Z Z-FPP comprising contacting Z 1 Z-YY with a recombinant or purified SB synthase having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with SEQ ID No. 4 under appropriate conditions and harvesting a mixture sesquiterpene SB type or derivatives thereof obtained. It relates to the use of a recombinant or purified SB synthase having at least 80%, 85%, 90%, 95%, 97%, 98% or 99% identity with the
• SEQ ID No. 4 for the preparation of a Class II sesquiterpene mixture or derivatives thereof from ZZ-FPP.
• an expression cassette comprises all the elements necessary for the transcription and translation of the gene into a protein.
• it comprises a promoter, possibly an amplifier, a transcription terminator and the elements allowing the translation.
• the promoter is adapted to the host cell.
• the promoter can be selected from the following promoters: LacI, LacZ, pLacT, ptac, pARA, pBAD, T3 or T7 bacteriophage RNA polymerase promoters, polyhedrin promoter, PR or PL promoter of phage lambda.
• the promoter may be selected from the following promoters: cytomegalovirus (CMV) early promoter, thymidine kinase promoter of the herpes simplex virus (herpes simplex virus, HSV), early or late promoter simian virus 40 (SV40), mouse metallothionein-L promoter, and LTR (long terminal repeat) regions of some retro viruses.
• CMV cytomegalovirus
• HSV herpes simplex virus
• SV40 early or late promoter simian virus 40
• mouse metallothionein-L promoter mouse metallothionein-L promoter
• LTR long terminal repeat
• the vector may be a plasmid, a phage, a phagemid, a cosmid, a virus, a YAC, a BAC, an Agrobacterium pTi plasmid, etc.
• the vector may preferably comprise one or more elements selected from an origin of replication, a multiple cloning site and a marker.
• the marker may be a reporter gene that generates a detectable signal.
• the detectable signal may be a fluorescent signal, a color, a light emission.
• the marker may therefore be GFP, EGFP, DsRed, beta-galactosidase, beta-glucosidase, luciferase, etc.
• the marker is preferably a selection marker providing the cell with resistance to an antibiotic or herbicide.
• the gene may be a resistance gene for kanamycin, neomycin, etc.
• the vector is a plasmid. Examples of prokaryotic vectors are listed in the following non-exhaustive list: pQE70, pQE60, pQE-9 (Qiagen), pbs, pDIO, phagescript, psiX174, pbluescript SK, pbsks, pNH8A, pNH16A, pNH18A, pNH46A (Stratagene) ); ptrc99a, pKK223-3, pKK233-3, pDR540, pBR322, and pRIT5 (Pharmacia), pET (Novagen) and pQE-30 (QIAGEN).
• eukaryotic vectors examples include pWLNEO, pSV2CAT, pPICZ, pcDNA3.1 (+) Hyg (Invitrogen), pOG44, pXT1, pSG (Stratagene); pSVK3, pBPV, pCI-neo (Stratagene), pMSG, pSVL (Pharmacia);
• the viral vectors may be non-exhaustively adenoviruses, AAVs, HSVs, lentiviruses, etc.
• the expression vector is a plasmid or a viral vector.
• the host cell may be a prokaryote, for example Escherichia coli, Bacillus subtilis, Streptomyces sp, and Pseudomonas sp or a eukaryotic.
• the eukaryote may be a lower eukaryote such as a yeast (eg, Saccharomyces cerevisiae) or a filamentous fungus (eg Aspergillus genus) or a higher eukaryote such as an insect, mammalian or plant cell.
• the cell may be a mammalian cell, for example a COS cell, CHO (US 4,889,803; US 5,047,335).
• the cell is non-human and non-embryonic.
• the cell can be isolated, for example in a culture medium.
• the cells may also be included in organisms, for example transgenic non-human animals or transgenic plants.
• the present invention therefore relates to a method for producing Z, Z-FPP or derivatives thereof from IPP and DMAP in a cell having a source of IPP and DMAP, comprising: a) introduction in said cell of a construct carrying an expression cassette comprising a gene encoding a Z, Z-FPP synthase according to the present invention; b) culturing the transformed cell under conditions appropriate for the expression of the gene; and, c) optionally, harvesting Z Z-FPP or derivatives thereof contained in said cell and / or in the culture medium.
• the Z, Z-FPP produced is harvested in step c).
• the Z Z-FPP product is the starting material to obtain another compound of interest such as ZZ-farnesol.
• ZZ-FPP can be converted to ZZ-farnesol by phosphatase.
• the method may further comprise in step a) the introduction of a construct carrying an expression cassette comprising a gene encoding a phosphatase, thus allowing the harvest of ZZ-farnesol in step c).
• the present invention therefore relates to a method for producing ZZ-FPP or derivatives thereof from IPP and DMAP in a recombinant cell having a source of IPP and DMAP and comprising a heterologous gene encoding a ZZ -FPP synthase according to the present invention.
• the present invention thus relates to a method for producing ZZ-FPP in a recombinant cell having a source of DMAP and IPPP, comprising: a) providing a recombinant cell comprising a heterologous gene encoding a zFPS according to the present invention; b) culturing the cell under conditions suitable for the expression of said gene; and, c) optionally, harvesting ZZ-FPP or derivatives thereof contained in said cell and / or in the culture medium.
• the present invention therefore relates to a method for producing a mixture of SB-type sesquiterpenes or derivatives thereof from ZZ-FPP in a cell having a ZZ-FPP source, comprising: a) introduction into said cell of a construct carrying an expression cassette comprising a gene encoding an SB synthase according to the present invention; b) culturing the transformed cell under conditions appropriate for the expression of the gene; and, c) optionally, harvesting an SB-type sesquiterpene mixture or derivatives thereof contained in said cell and / or in the culture medium.
• the SB-type sesquiterpene mixture produced is harvested in step c).
• the SB type sesquiterpenes mixture produced is the starting material to obtain other compounds of interest such as alpha-santalol.
• the present invention therefore relates to a method for producing a SB-type sesquiterpene mixture or derivatives thereof from
• the present invention thus relates to a method for producing SB-type sesquiterpenes or derivatives thereof from ZZ-FPP in a recombinant cell having a ZZ-FPP source, comprising: a) providing a recombinant cell comprising a heterologous gene encoding an SB synthase according to the present invention; b) culturing the cell under conditions suitable for the expression of said gene; and, c) optionally, harvesting SB-type sesquiterpenes or derivatives thereof contained in said cell and / or in the culture medium.
• the cell may also be part of a multicellular organism, for example a non-human plant or animal.
• the present invention relates to a method for preparing a multicellular organism comprising: a) introducing into a cell of the organism a construct carrying an expression cassette comprising a first gene coding for a ZZ- FPP synthase according to the present invention and a construct carrying an expression cassette comprising a second gene encoding an SB synthase according to the present invention; and, b) reconstituting an organism from said cell and selecting transgenic organisms expressing both introduced genes.
• the organism is a non-human animal.
• the body can be a mouse, a rat, a guinea pig, a rabbit, etc.
• the organism is a plant, preferably a glandular trichome plant.
• the present invention therefore relates to a method for producing a mixture of SB-type sesquiterpenes comprising the provision of a multicellular organism transgenic expressing a Z Z-FPP synthase according to the present invention and an SB synthase according to the present invention and harvesting a mixture of SB-type sesquiterpenes produced or derivatives thereof in said transgenic organisms.
• the method makes it possible to produce an SB-type sesquiterpene mixture to organisms that do not produce these compounds or to increase the amount of a SB-type sesquiterpene mixture produced by organisms already producing it.
• the present invention relates to a method for preparing a multicellular organism comprising: a) introducing into a cell of the organism a construct carrying an expression cassette comprising a gene coding for a Z, Z-FPP synthase according to the present invention; and b) reconstituting an organism from said cell and selecting transgenic organisms expressing the introduced gene.
• the present invention also relates to a method for producing Z Z-FPP or derivatives thereof comprising comprising providing a transgenic multicellular organism expressing a ZZ-FPP synthase according to the present invention and harvesting ZZ-FPP produced or derivatives thereof in said transgenic organisms.
• the organism is a non-human animal.
• the body can be a mouse, a rat, a guinea pig, a rabbit, etc.
• the organism is a plant, preferably a glandular trichome plant. The method allows ZZ-FPP to be produced from organisms that do not produce this compound or to increase the amount of ZZ-FPP produced by organisms.
• the present invention relates to a method for preparing a multicellular organism comprising: a) introducing into a cell of the organism a construct carrying an expression cassette comprising a gene encoding an SB synthase according to the present invention; and b) reconstituting an organism from said cell and selecting the transgenic organisms expressing the introduced gene.
• the present invention relates to a method for producing a SB-type sesquiterpene mixture or derivatives thereof comprising providing a transgenic multicellular organism expressing an SB synthase according to the present invention and harvesting a sesquiterpene mixture. of SB type product or derivatives thereof in said transgenic organisms.
• the organism is a non-human animal.
• the body can be a mouse, a rat, a guinea pig, a rabbit, etc.
• the organism is a plant, preferably a plant with secretory trichomes. The method makes it possible to produce a mixture of SB-type sesquiterpenes to organisms that do not produce this compound or to increase the amount of a mixture of SB-type sesquiterpenes produced by organisms.
• the invention is particularly applicable to all plants of families with glandular trichomes, for example the Asteraceae (sunflower, etc.), Solanaceae (tomato, tobacco, potato, pepper, eggplant, etc.), Cannabaceae (ex Cannabis sativa) and Lamiaceae (mint, basil, lavender, thyme, etc.). It is particularly suitable for plants of the family Solanaceae, such as for example the genera Nicotiana, Solanum, Capsicum, Petunia, Datura, Atropa, etc., and in particular of the genera Solanum and Nicotiana, for example the cultivated tomato (Solanum tycopersicum).
• the invention can be applied to plants of the following genera: Populus, Nicotiana, Cannabis, Pharbitis, Apteria, Psychotria, Mercurialis, Chrysanthemum, Polypodium, Pelargonium, Mimulus, Matricaria, Monarda, Solanum, Achillea, Valeriana, Ocimum, Medicago, Aesculus, Plumbago, Pityrogramma, Phacelia, Avicennia, Tamarix, Frankenia, Limonium, Foeniculum, Thymus, Salvia, Kadsura, Beyeria, Humulus, Mentha, Artemisia, Nepta, Geraea, Pogostemon, Majorana, Cleome, Cnicus, Parthenium, Ricinocarpos, Hymennaea
• the plant is a plant of the family Asteraceae, Cannabaceae, Solanaceae or Lamiaceae.
• the plant belongs to the genera Solanum or Nicotiana, preferably Solanum esculentum, Solanum haplochaites, Nicotiana tabacum or Nicotiana sylvestris.
• the genes are placed under the control of a promoter allowing expression, preferably specific, in the trichomes of the plant.
• a promoter allowing expression, preferably specific, in the trichomes of the plant.
• the term "specific" promoter is understood to mean a promoter mainly active in a given tissue or cell group. It is understood that a residual expression, generally lower, in other tissues or cells can not be entirely excluded.
• a particular characteristic of the invention resides in the capacity to construct specific promoters of the secretory cells of the glandular trichomes, allowing a modification of the composition of the foliar secretions of the plant, and in particular to express the genes of the present invention making it possible to prepare the SB-type sesquiterpene mixture.
• ZZ-FPP, and the mixture of SB-type sesquiterpenes or derivatives thereof can be harvested from the trichomes of these plants, particularly in the exudate of trichomes by extraction with a solvent or by distillation. .
• the promoter used in the cassette is derived from the Nicotiana sylvestris NsTPS-02a, 02b, 03, and 04 genes with strong sequence similarity to CYC-2 (CBT-1). ol cyclase, NID: AF401234). These promoter sequences are more fully described in the patent application WO2006040479 (Tissier et al., 2004).
• Preferred terminator sequences include the NOS terminator (Bevan et al., 1983), and the histone gene terminator (EPO 633,317).
• the expression cassette may comprise a sequence for increasing expression (“enhancer"), for example certain elements of the CaMV35S promoter and octopine synthase genes (US 5,290,924). .
• the activating elements of the CaMV35S promoter are used.
• constructs carrying one or both of the genes of the invention into a plant cell or tissue, including a seed or plant can be carried out by any technique known to those skilled in the art, including in episomal form or chromosome.
• Plant transgenesis techniques are well known in the art, and include, for example, the use of the bacterium Agrobacterium tumefaciens, electroporation, biolistic techniques, transfection with a viral vector in particular, and any other technique known to those skilled in the art. .
• a commonly used technique is based on the use of the bacterium Agrobacterium tumefaciens, which consists essentially in introducing the construction of interest (nucleic acid, cassette, vector, etc.) into the bacterium A. tumefaciens, and then bringing this bacterium into contact transformed with leaf discs of the chosen plant.
• the introduction of the expression cassette into the bacterium is typically carried out using Ti (or T-DNA) plasmid as vector, which can be transferred into the bacterium, for example by thermal shock or electroporation. Incubation of the transformed bacterium with the leaf disks makes it possible to obtain the transfer of the Ti plasmid into the genome of the cells of the disks.
• transgenic plants may optionally be grown under conditions suitable for reconstituting a transgenic plant whose cells comprise the construction of the invention.
• A. tumefaciens one can refer for example to Horsch et al. (1985) or
• the expression cassette thus formed is inserted between the left and right borders of the transfer DNA (T-DNA) of a disarmed Ti plasmid for transfer into plant cells by Agrobacterium. tumefaciens.
• T-DNA also includes a gene whose expression confers resistance to an antibiotic or a herbicide and which allows the selection of transformants.
• the transgenic plants may be tested for heterologous expression of the genes of the present invention or the production of a mixture of SB-type sesquiterpenes, ZZ-FPP or ZZ-farnesol in trichomes. This can be accomplished by harvesting leaf exudate and testing for the presence of the product of interest in this exudate. The analysis of the volatiles emitted by the plant can also make it possible to identify the said compounds. This can also be done by analyzing the presence of one or more heterologous enzymes of the present invention in the leaves and, more particularly, in the trichome cells (for example by analyzing mRNA or genomic DNA using probes or specific primers). Plants can optionally be selected, crossed, processed, etc. to obtain plants with improved levels of expression.
• Another subject of the invention also resides in a plant or seed comprising a nucleic acid, an expression cassette or a vector as defined above.
• Another subject of the invention relates to the use of a nucleic acid of the present invention as molecular markers to allow the introduction of the corresponding genomic sequences of S. habrochaites into other species or varieties of cultivated tomato (S. tycopersicum). ) sexually compatible. Indeed, these markers make it possible to control the introduction of the corresponding genomic sequences of S. habrochaites into other sexually compatible species or varieties of cultivated tomato (S. tycopersicum) and thus, for example, to identify and select individuals. from a cross between the wild species and a cultured species in which introgression of the nucleic acids of the present invention has occurred.
• the use of the nucleic acids of the present invention as molecular markers can be performed by any technique known to those skilled in the art.
• a commonly used technique relies on the identification of a band polymorphism (RFLP) between two genomes digested by different restriction enzymes by molecular hybridization with the nucleic acids of the present invention.
• Another example is to look for a polymorphism using the PCR technique to amplify on the genomes to compare all or part of a nucleic acid of the present invention from primers complementary to the nucleic acid of the present invention for identify after PCR amplification a size polymorphism between the two genomes.
• the polymorphism can also be revealed after digestion of said PCR products by one or more restriction enzymes which will reveal fragments of different size between the compared genomes.
• this information is used, for example, to identify individuals of an F2 population derived from a cross between S. habrochaites and a tomato variety in which the introgression of the nucleic acids of the present invention is desired.
• Another subject of the invention relates to the introduction of genomic sequences of S. habrochaites coding for zFPS and SB synthase in species which are not sexually compatible by cell fusion, in particular protoplasts.
• Protoplast fusion techniques are known to those skilled in the art (Zimmermann et al, 1981, Bâtes et al, 1983), and allow to create hybrid cells containing chromosomes belonging to the two fused species. Upon fusion of chromosomes or chromosome fragments of both species are eliminated.
• Hybrid cells having preserved the chromosomal fragment (s) containing the genes of the present invention can then be selected by PCR using primers specific for the gene coding for zFPS (SEQ ID No. 1) or that coding for SB synthase ( SEQ ID NO: 2) or both.
• the present invention finally relates to a non-human transgenic cell or organism, characterized in that the synthesis route of a SB-type sesquiterpene mixture is blocked by inactivation of the gene coding for a Z, Z-FPP synthase according to the present invention.
• invention or gene encoding an SB synthase according to the present invention or both genes can be blocked by many techniques available and known to those skilled in the art. Genes can be deleted, mutated (by example by chemical mutagenesis by ethyl methane sulphonate or by ionizing radiation) or interrupted (insertional mutagenesis). Moreover, the blocking of the expression of these genes can also be achieved by gene silencing by expressing an inhibitory transcript.
• the inhibitory transcript is an RNA which can be in the form of a double-stranded RNA, an antisense RNA, a ribozyme, an RNA capable of forming a triple helix, and which has a certain complementarity or specificity with the transcript of the gene to block.
• the present invention also relates to a nucleic acid capable of decreasing or suppressing the expression of a gene encoding a Z, Z-FPP synthase.
• a nucleic acid capable of decreasing or suppressing the expression of a gene encoding a Z, Z-FPP synthase.
• an inhibitory RNA which can be in the form of a double-stranded RNA, an antisense RNA, a ribozyme, an RNA capable of forming a triple helix, and which has a certain complementarity or specificity with the gene encoding Z 1 Z-YY? Synthase can be prepared on the basis of the teaching of the present invention.
• the present invention relates to an inhibitory RNA of the gene encoding a ZZ-FPP synthase comprising at least 21, 30, 40, 50, 60, 70, 80, 90 or 100 consecutive nucleotides of SEQ ID No. 1 or a sequence complementary to it.
• a polynucleotide comprising at least 21, 30, 40, 50, 60, 70, 80, 90 or 100 consecutive nucleotides of SEQ ID No. 1 or a complementary sequence thereof. to inhibit the expression of the gene encoding a Z 1 Z-YY? synthase.
• Inhibition of this enzyme may be useful for stopping or slowing down the SB-type sesquiterpene mixture synthesis pathway and making IPP and DMAP available for another synthetic route of interest requiring Z, ZF? ?.
• the inhibition of this enzyme may make it possible to increase the germacrene production rate B by the glandular cells of tomato leaf trichomes.
• the present invention thus relates to transgenic cells or organisms in which the gene encoding a Z, Z-FPP synthase has been inactivated. Inactivation can be performed by interfering RNA, gene deletion, chemical mutation or homologous recombination inactivation techniques. Thus the level of ZZ-FPP or SB-type sesquiterpene mixture can be decreased in these transgenic cells or organisms.
• the present invention also relates to a nucleic acid capable of decreasing or suppressing the expression of a gene encoding an SB synthase.
• an inhibitory RNA which may be in the form of a double-stranded RNA, an antisense RNA, of a ribozyme, an RNA capable of forming a triple helix, and which has some complementarity or specificity with the gene encoding an SB synthase can be prepared on the basis of the teaching of the present invention.
• the present invention relates to an inhibitory RNA of the gene encoding an SB synthase comprising at least 30, 40, 50, 60, 70, 80, 90 or 100 consecutive nucleotides of SEQ ID No. 3.
• a polynucleotide comprising at least 21, 30, 40, 50, 60, 70, 80, 90 or 100 consecutive nucleotides of SEQ ID No. 3 for inhibiting the expression of the gene coding for an SB synthase.
• Inhibition of this enzyme may be useful for stopping the synthesis pathway of a SB-type sesquiterpene mixture and making the ZZ-FPP available for another synthetic route of interest requiring an addition of this compound, for example to prepare ZZ-FPP derivatives, for example Z, Z farnesol, or other sesquiterpenes which are the product of synthases using ZZ-FPP as the substrate.
• the present invention thus relates to transgenic cells or organisms in which the gene encoding an SB synthase is inactivated. Inactivation can be performed by interfering RNA, gene deletion, chemical mutation or homologous recombination inactivation techniques. Thus, the level of SB-type sesquiterpenes mixture can be decreased in these transgenic cells or organisms.
• the present invention also relates to a method for identifying or cloning other genes encoding ZZ-FPP synthase or SB synthase from another species in which a probe having at least 15, 30, 50, 75, 100, 200 or 300 consecutive nucleotides of the sequence SEQ ID No. 1 or 3, respectively, is prepared and used to identify or select in a sample a nucleotide sequence capable of hybridizing to said probe.
• the sample may be, for example, a genomic or cDNA library from one or more organisms.
• the method may include an additional step of characterizing the identified or selected sequence. This additional step may include cloning, and / or sequencing, and / or sequence alignment, and / or enzymatic activity testing.
• the corresponding cDNAs were synthesized by reverse transcription from a polyT primer using a reverse transcriptase (Roche, Cat No. 03 531 317) under the reaction conditions recommended by the manufacturer.
• the coding and complete nucleotide sequences for the two Sh-zFPS and Sh-SBS genes were cloned from the public information of sequences of the EST library of S. habrochaite tomato leaf trichomes (Van der Hoeven, et al. ., 2000, unpublished,) obtained from the SGN website ("SOL Genomics Network", http://www.sgn.cornell.edu/).
• Sh-zFPS SEQ ID No. 1
• Sh-SBS SEQ ID No. 3
• sequences of Sh-zFPS were obtained by PCR from the tomato leaf cDNAs using the primers 5'-ACCATGGGTTCTTTGGTTCTTCAATGTTGGA-3 '(SEQ ID NO. ID No. 5) and 5'-ACTCGAGATATGTGTGTCCACCAAAACGTCTATG-3 '(SEQ ID No. 6) for sequence ID No. 1 and primers 5'-T ⁇ CATGGTAGTTGGCTAT AGAAGCAC AATC A-3' (SEQ ID No. 7) and 5'-TCTCGAGC ATAAATTC AAATTGAGGGATTAATGA-3 '(SEQ ID No. 8) for the sequence ID No. 3.
• PCR amplification was performed with 0.5 units of Taq polymerase (Eurogentec) in the buffer provided by the manufacturer.
• the PCR product was purified on a Qiaquick column (Qiagen) and ligated with T4 DNA ligase (NEB) into the pGEM-T cloning vector (Promega).
• the clones corresponding to the expected sequence were selected after complete sequencing of the inserts.
• the nucleotide sequence Sh-zFPS (SEQ ID No. 1) has a length of 912 bases and encodes a protein (SEQ ID No.
• 5% -zFPS has an identity percentage of 42% and 39% with putative UPPS of Arabidopis thaliana BAA97345 and AAO63349 respectively. It may also be noted that the 5% -ZFPS sequence has a very low degree of identity (24%) with Z, is-FPS of Micrococcus tuberculosis (053434).
• Micrococcus luteus 082827 Pose UPPS 34 Gloeobacer violaceus O7NPE7 32 "
• Table 1 Sequences presenting the highest percentage identity (% identity) obtained by homology search with the BlastP 2.2.13 program (Altschul et al, 1997) against the SwissProt and GenBank banks with the STz-zFPS sequence.
• the nucleotide sequence Sh-SBS (SEQ ID No. 3) has a length of 2334 bases and encodes a protein (SEQ ID No. 4) of 777 amino acids.
• a conserved terpene cyclase protein domain (cd00684.2) has been identified "in silico" with the CCD system (NCBI, Marchler-Bauer A, Bryant SH, 2004. Similar amino acid sequences to Sh-SBS have been sought.
• Table 2 Sequences presenting the best percentage of identity (% identity) obtained by homology search with the program BlastP 2.2.13 (Altschul et al, 1997) against the banks of SwissProt and GenBank with the sequence Sh-SBS.
• Nucleic sequences encoding 5% -ZFPS and 5% -SBS were separately introduced into the pET-30b expression vector (Novagen). To enable the purification of the recombinant proteins, the STOP codons of these sequences were deleted in order to create a fusion protein with a six-histidine tail at the C-terminus.
• the vectors pET30b--zFPS 5% and 5% -SBS-pET30b thus obtained were introduced by electroporation into cells of Escherichia coli modified for the expression of recombinant proteins (BL21-CodonPlus, Stratagene). For the production of proteins, cultures (500 ml) of E.
• coli are initiated at 37 ° C. to an optical density of 0.5 to 600 nm.
• the culture temperature is lowered to 16 ° C. and ethanol (1%, v / v) is added to the media.
• IPTG is added to the medium at a concentration of 1 mM to induce the expression of the recombinant protein.
• the culture is then incubated for a duration of 18 hours.
• the culture is stopped by centrifugation of the cells at 4 ° C.
• the cell pellet is taken up in 20 mM phosphate buffer.
• the cells are lysed to the French press
• the lysates are centrifuged at 15,000xg.
• the supernatants containing the solubilized proteins are desalted on a PD10 column (Amersham), equilibrated with a phosphate buffer (pH 7, 50 mM), and then applied to a nickel-nitrilotriacetic affinity resin (Ni-NTA, Qiagen).
• Ni-NTA nickel-nitrilotriacetic affinity resin
• the manufacturer's elution protocol is strictly followed.
• the most enriched fractions of proteins Sh-zFPS-6His and Sh-SBS-6His are identified by SDS-PAGE gel, then desalted on PD10, equilibrated with a buffer (50 mM Hepes, pH 7.8, 100 mM KCl). An enrichment factor of about 20 was obtained for both proteins relative to the crude protein fraction.
• the activity tests are carried out in a buffer having the following composition: 50 mM Hepes, pH 7.8, 100 mM KCl, 7.5 mM MgCl 2 , 5% glycerol (w / v), and 5 mM DTT.
• 50 mM Hepes, pH 7.8, 100 mM KCl, 7.5 mM MgCl 2 , 5% glycerol (w / v), and 5 mM DTT for the activity tests, 25 or 50 ⁇ g of proteins from the enriched fraction were incubated with the substrates IPP, DMAPP, GPP, FPP, GGPP (Sigma), alone or in combination, at a concentration of 65 ⁇ M each at 32. 0 C for 2 hours.
• the products of the reaction are then dephosphorylated by adding 20 units of calf intestinal alkaline phosphatase (New England Biolabs) for 1 hour at 37 ° C.
• Terpenes alcohols products dephosphorylation are then extracted with chloroform: methanol: water (0.5: 1: 0.4).
• the aqueous and organic phases are separated by addition of water (0.5 vol) and chloroform (0.5 vol), and centrifuged (2.000 ⁇ g).
• the organic phases are removed and dried under a stream of nitrogen gas, taken up in pentane and analyzed by gas chromatography coupled to a mass spectrometer (GC-MS 5973N, Agilent Technologies).
• Terpene alcohols are identified by comparing their mass spectrum with those of the National Institute of Standards and Technology (NIST) database, and by superimposing retention times with standards of geraniol, farnesol and geranylgeraniol (Fluka).
• the terpenes produced in the reaction are directly extracted (3 times) from the reaction mixtures with pentane (volume to volume).
• the 3 pentane extracts are pooled, concentrated under a stream of nitrogen gas, and analyzed by GC-MS.
• the terpenes produced are identified by interrogation of the base of NIST data and comparison with a chromatogram of Solarium exudate extract haplochaites.
• the recombinant Sh-zFPS-6His protein was incubated with the substrates IPP + DMAPP or IPP + GPP (see Table 1). Only the first combination (IPP + DMAPP) leads, after dephosphorylation, to the formation of a single alcohol terpene of 15 carbon atoms
• Sh-zFPS-6His has a retention time identical to that of ZZ-farnesol
• the recombinant Sh-SBS-6His protein was incubated with the substrates GPP, FPP and GGPP. Regardless of the substrate used, no new terpene could be detected, meaning that the enzyme is inactive on the trans-allylic substrates (Table 1).
• Table 3 Summary of enzymatic activity tests obtained in vitro with recombinant 57z-zFPS-6His and 57z-SBS-6His proteins according to different isoprenic substrates used.
• A Z, Z-farnesol
• B alpha-santalene
• C epi-beta-santalene
• D endo-beta-bergamotene
• E cis-alpha-bergamotene
• F trans-alpha-bergamotene.
• the enzymes 5% -ZFPS-6His and 5% -SBS-6His were incubated together with the substrates DMAPP and IPP or GPP and IPP.
• the reaction product was not treated with phosphatase, but extracted with pentane in which any olefin is soluble.
• DMAPP and PIPP as substrates, chromatographic analysis of the extract reveals the presence of several terpene compounds (Fig. 5).
• the GC profile was compared to the exudate of tomato line TA517.
• This line is a quasi-isogenic line obtained from the parents S. tycopersicum and S. habrochaites (Monforte and Tanks ley, 2000).
• the TA517 line has an introgression fragment of S. habrochaites responsible for the biosynthesis of Class II sesquiterpenes (van der Hoeven et al, 2000).
• the two GC profiles are identical, which confirms that the recombinant enzymes have an activity strictly identical to those present in the tomato (Figure 6).
• the major compound (Fig. 5, peak 2) is identified as alpha-santalene by comparing its retention time and mass spectrum with that of TA517 tomato exudate extract.
• alpha-santalene peak 4
• endo-beta-bergamotene peak 5
• alpha-bergamotene peak 1
• Sh-zFPS is an enzyme that acts on PPI and DMAPP to produce a phosphorylated compound of the farnesyl diphosphate type.
• the retention time is identical to the standard (Z, Z) -farnesol indicating that the farnesyldiphosphate produced by Sh-zFPS is characterized by a configuration of Z, Z type.
• the inactivity of Sh-zFPS-6His on is-geranyl diphosphate in combination with IPP indicates that this molecule is not an intermediate product of Sh-zFPS-6His and produces at least one Z-type bond by combining a DMAPP and an IPP.
• Sh-SBS is active only on the farnesyldiphosphate compound produced by the enzyme Sh-zFPS, but produces at least 4 clearly identified sesquiterpenes, the majority of which is alpha-santalene. Finally, the presence of a C-terminal extension by a spacer and 6 histidines, does not modify the activity of the enzyme relative to the native enzymes of the plant of origin (Fig. 3).
• a trichome-specific tobacco promoter (eCBTS02, Tissier et al, 2004) was cloned upstream of the Sh-zFPS and Sh-SBS coding sequences to form the constructs eCBTSl.O-Sh-zFPS 1 [# 1] and eCBTS1. 0-S ⁇ - ⁇ SaS [# 2].
• eCBTSl.O-Sh-zFPS 1 [# 1] eCBTS1.
• 0-S ⁇ - ⁇ SaS [# 2] 0-S ⁇ - ⁇ SaS [# 2].
• These two constructs were introduced into the same binary vector for Agrobacterium transformation, containing a kanamycin resistance gene to yield the pLIBRO-064 binary vector (Fig. 2A).
• Construction # 2 was also independently introduced into a binary vector pLIBRO-065 (Fig. 2B).
• the vectors were introduced into the Agrobacterium strain LBA4404 by electroporation.
• the strains containing the different vectors were used to carry out the genetic transformation of N. sylvestris by the leaf disk method (Horsch et al, 1985).
• Transgene-bearing T-DNAs were introduced by genetic transformation into a transgenic N. sylvestris line (ihpCBTS source line) whose expression of the CBTS gene was inhibited by RNA interference (Tissier et al., 2005). In this line, the amount of CBT-diol of the leaves is very small.
• N. sylvestris a wild tobacco does not produce sesquiterpenes equivalent to those of tomato. About 25 kanamycin resistant plants were obtained for each construct.
• transgenes in each plant were confirmed by PCR from genomic leaf DNA.
• the expression level of the transgenes in the leaves was verified by real-time quantitative PCR from mRNA of tobacco leaves.
• the level of expression of the Sh-SBS transgene was compared to that of an actin gene whose expression is constitutive in tobacco leaves.
• the results are shown in Figure 3 as an example. They indicate that the selected lines all express the transgene at levels varying from 1 to 50 for the pLIBRO-064 construct and from 1 to 10 for the pLIBRO-065 construct relative to the actin gene.
• olefinic sesquiterpenes are volatile molecules
• the volatile molecules emitted by plants have been analyzed in a controlled atmosphere in a culture chamber. Part of the atmosphere was captured in a bypass circuit containing a SuperQ® filter (Altech) with the ability to adsorb olefinic terpene molecules. The molecules were then eluted with 1 ml of pentane and analyzed by GC / MS.
• An example of a chromatographic profile of the volatile molecules emitted by a transgenic plant is presented in FIG. 7. It shows that the line # 3877 expressing the Sh-zFPS and Sh-SBS genes contains several new peaks having a molecular ion signature.
• chromatographic profile was compared with that obtained from the exudate of tomato line TA517 which naturally produces these compounds (Fig. 7). The two profiles are identical and the mass spectra of each of the peaks are identical to those of the peaks of the TA517 line.
• Plants that express both Sh-zFPS and Sh-SBS transgenes produce alpha-santalene, epi-beta-santalene, cis-alpha-bergamotene, trans-alpha-bergamotene, and endotoxin. beta-bergamotene whereas transgenic lines that have integrated the Sh-SBS gene alone do not produce any of these compounds.
• the zFPS complete gene was amplified by PCR from S. lycopersicum, S. habrochaites and TA517 genomic DNA using primers ACCATGGGTTCTTTGGTTCTTCAATGTTGGA (SEQ ID NO 9) and ACTCGAGATATGTGTGTCCACCAAAACGTCTATG (SEQ ID NO 10).
• Two products were amplified in both genomes indicating that there are at least two copies of the gene in both genomes (Fig. 8).
• One of the two products which has a size of about 3000 nucleotides (band A) is common to both genomes.
• the second product has a size of about 2000 nucleotides (band C) in S. lycopersicum and about 2500 nucleotides (band B) in S.
• the line TA517 shows a profile identical to that of S. habrochaites.
• Bohlmann J, Crock J, Jetter R, Croteau R. (1998) Terpenoid-based defenses in conifers: cDNA cloning, characterization, and functional expression of wound-inducible (E) -alpha-bisabolene synthase from grand fir (Abies grandis). Proc Natl Acad Sci U S 1998 1998: 6756-6761. Bouwmeester HJ, Kodde J, Verstappen FW, Altug IG, Kraker JW, Wallaart TE.
• Facchini PJ Chappell J. Gene family for an elicitor-induced sesquiterpene cyclase in tobacco (1992) Proc Natl Acad Sci 89 (22): 11088-11092. Heinstein PF, Herman DL, SB Tove, Smith FH. Biosynthesis of gossypol.
• Citrus fruit fiavor and aroma biosynthesis isolation, functional characterization, and developmental regulation of Cstpsl, a key gene in the production of the sesquiterpene aroma compound valencene. Plant J. 2003 36: 664-74.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Genetics & Genomics (AREA)
• Organic Chemistry (AREA)
• Wood Science & Technology (AREA)
• Zoology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biotechnology (AREA)
• General Engineering & Computer Science (AREA)
• Microbiology (AREA)
• General Health & Medical Sciences (AREA)
• Biochemistry (AREA)
• Biomedical Technology (AREA)
• Molecular Biology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Plant Pathology (AREA)
• Biophysics (AREA)
• Physics & Mathematics (AREA)
• Medicinal Chemistry (AREA)
• Cell Biology (AREA)
• Nutrition Science (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Enzymes And Modification Thereof (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Priority Applications (7)

Applications Claiming Priority (2)

Related Child Applications (2)

Publications (2)

Family

ID=38670598

Family Applications (1)

Country Status (8)

Cited By (5)

Families Citing this family (21)

Citations (7)

Family Cites Families (9)

• 2007
  • 2007-04-03 FR FR0754235A patent/FR2914652B1/fr not_active Expired - Fee Related
• 2008
  • 2008-04-02 ES ES08788102T patent/ES2426388T3/es active Active
  • 2008-04-02 JP JP2010501569A patent/JP5369089B2/ja not_active Expired - Fee Related
  • 2008-04-02 EP EP08788102.5A patent/EP2132305B1/fr not_active Not-in-force
  • 2008-04-02 CA CA002681878A patent/CA2681878A1/fr not_active Abandoned
  • 2008-04-02 US US12/593,688 patent/US8629321B2/en not_active Expired - Fee Related
  • 2008-04-02 WO PCT/FR2008/050576 patent/WO2008142318A2/fr not_active Ceased
  • 2008-04-02 CN CN2008800113106A patent/CN101688191B/zh not_active Expired - Fee Related
• 2013
  • 2013-12-30 US US14/143,539 patent/US20140154768A1/en not_active Abandoned

Patent Citations (7)

Non-Patent Citations (40)

Also Published As

Similar Documents

Legal Events